| Target and Pathway |
Top |
| Target(s) |
Tumor necrosis factor receptor type I (TNF-R1) |
Target Info
|
Modulator |
[1] |
|
KEGG Pathway
|
MAPK signaling pathway
|
|
Cytokine-cytokine receptor interaction
|
|
NF-kappa B signaling pathway
|
|
Sphingolipid signaling pathway
|
|
Apoptosis
|
|
Osteoclast differentiation
|
|
TNF signaling pathway
|
|
Adipocytokine signaling pathway
|
|
Non-alcoholic fatty liver disease (NAFLD)
|
|
Alzheimer's disease
|
|
Amyotrophic lateral sclerosis (ALS)
|
|
Chagas disease (American trypanosomiasis)
|
|
Toxoplasmosis
|
|
Tuberculosis
|
|
Hepatitis C
|
|
Influenza A
|
|
HTLV-I infection
|
|
Herpes simplex infection
|
|
NetPath Pathway
|
TGF_beta_Receptor Signaling Pathway
|
|
TCR Signaling Pathway
|
|
Panther Pathway
|
Apoptosis signaling pathway
|
|
Pathway Interaction Database
|
Canonical NF-kappaB pathway
|
|
Signaling events mediated by HDAC Class I
|
|
TNF receptor signaling pathway
|
|
Ceramide signaling pathway
|
|
HIV-1 Nef: Negative effector of Fas and TNF-alpha
|
|
Caspase Cascade in Apoptosis
|
|
Reactome
|
TNFR1-induced proapoptotic signaling
|
|
Regulation of TNFR1 signaling
|
|
TNFR1-induced NFkappaB signaling pathway
|
|
TNFR1-mediated ceramide production
|
|
TNFs bind their physiological receptors
|
|
TNF signaling
|
|
WikiPathways
|
Inflammatory Response Pathway
|
|
Apoptosis Modulation by HSP70
|
|
Cardiac Hypertrophic Response
|
|
Apoptosis
|
|
Nanoparticle triggered regulated necrosis
|
|
Amyotrophic lateral sclerosis (ALS)
|
|
Integrated Pancreatic Cancer Pathway
|
|
TNF alpha Signaling Pathway
|
|
Alzheimers Disease
|
|
Extrinsic Pathway for Apoptosis
|
|
Apoptosis Modulation and Signaling
|
